Suppr超能文献

蒙古乌兰巴托地区 2015-2016 年 2-59 月龄儿童肺炎球菌结合疫苗问世前的肺炎流行病学研究

Epidemiology of pneumonia in the pre-pneumococcal conjugate vaccine era in children 2-59 months of age, in Ulaanbaatar, Mongolia, 2015-2016.

机构信息

New Vaccines, Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Vic., Australia.

Department of Paediatrics, The University of Melbourne, Parkville, Australia.

出版信息

PLoS One. 2019 Sep 11;14(9):e0222423. doi: 10.1371/journal.pone.0222423. eCollection 2019.

Abstract

BACKGROUND

Respiratory diseases, including pneumonia, are the second largest cause of under-five mortality in Mongolia and the most common cause of childhood hospitalization. However information regarding the contribution of Streptococcus pneumoniae to pneumonia causation in Mongolia is limited. We aimed to describe the epidemiology of hospitalized children aged 2-59 months with pneumonia, enrolled into a surveillance program in the period prior to pneumococcal conjugate vaccine (PCV) introduction, in Mongolia.

METHODS

An expanded pneumonia surveillance program enrolled children, who met the surveillance case definition, at participating hospitals, between April 2015 and May 2016. Cumulative incidence rates were calculated by district for all pneumonia endpoints using district specific denominators from the Mongolian Health Department census for 2016. Socio-economic and disease-associated factors were compared between districts using chi-squared tests.

RESULTS

A total of 4318 eligible children with pneumonia were enrolled over the 14 month period. Overall the incidence for all-cause pneumonia in children aged 12-59 months was 31.8 per 1000 population; children aged 2-11 months had an almost four-fold higher incidence than children aged 12-59 months. Differences were found between districts with regards to housing type, fuel used for cooking, hospital admission practices and the proportions of severe and primary endpoint pneumonia.

DISCUSSION

This study shows a high burden of pneumonia in children aged 2-59 months in Mongolia prior to PCV introduction. Rates differed somewhat by district and age group and were influenced by a number of socio-economic factors. It will be important to consider these differences and risk factors when assessing the impact of PCV introduction.

摘要

背景

在蒙古国,呼吸道疾病(包括肺炎)是导致五岁以下儿童死亡的第二大原因,也是儿童住院的最常见原因。然而,有关肺炎病因中肺炎链球菌的作用的信息有限。我们旨在描述在引入肺炎球菌结合疫苗(PCV)之前,在蒙古国,参加监测项目的 2-59 月龄住院儿童肺炎的流行病学。

方法

在 2015 年 4 月至 2016 年 5 月期间,在参与医院通过扩大肺炎监测项目,招募符合监测病例定义的儿童。使用蒙古卫生部 2016 年普查的地区特定分母,按地区计算所有肺炎终点的累积发病率。使用卡方检验比较地区间的社会经济和疾病相关因素。

结果

在 14 个月的时间内,共招募了 4318 名符合条件的肺炎儿童。总体而言,12-59 月龄儿童的所有原因肺炎发病率为 31.8/1000 人;2-11 月龄儿童的发病率几乎是 12-59 月龄儿童的四倍。在住房类型、烹饪用燃料、住院治疗做法以及严重和主要终点肺炎的比例方面,各地区之间存在差异。

讨论

在引入 PCV 之前,本研究显示蒙古国 2-59 月龄儿童肺炎负担沉重。各地区和年龄组的发病率略有不同,受到许多社会经济因素的影响。在评估 PCV 引入的影响时,考虑这些差异和风险因素非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6bd4/6738602/e3bf5f84a7b6/pone.0222423.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验